🔗 Permalink

Inventor profile of:

Elfrida Benjamin

City:

Millstone Twp., New Jersey

Country:

United States

Published Applications:

Last publication date:

2026-04-09

Top Assignees for applications by Elfrida Benjamin

The entities that hold a legal rights for patent applications filed by inventor Benjamin Elfrida:

Amicus Therapeutics, Inc. 41 Philadelphia, PA United States
AMICUS THERAPEUTICS, INC. 27 Cranbury, NJ United States
Amicus Therapeutics, Inc. 1 Phildadelphia, PA United States

Recent patent applications by Benjamin Elfrida

Elfrida Benjamin from Millstone Twp., US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-09

US20260097027A1

Human necessities

Methods Of Treating Fabry Patients Having Renal Impairment

#2 | 2025-03-13

US20250082621A9

Human necessities

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

#3 | 2024-09-05

US20240293436A1

Human necessities

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

#4 | 2024-08-22

US20240277687A1

Human necessities

METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENE

#5 | 2024-06-27

US20240207295A1

Human necessities

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

#6 | 2024-04-18

US20240122911A1

Human necessities

Methods of treating Fabry patients having renal impairment

#7 | 2023-11-30

US20230381165A1

Human necessities

Methods of treating Fabry patients having renal impairment

#8 | 2023-11-30

US20230381164A1

Human necessities

Methods of treating Fabry patients having renal impairment

#9 | 2023-07-13

US20230218599A1

Human necessities

Methods of treating fabry patients having renal impairment

#10 | 2023-07-13

US20230218598A1

Human necessities

Methods of treating Fabry patients having renal impairment

#11 | 2023-06-29

US20230201180A1

Human necessities

Methods of treating Fabry patients having renal impairment

#12 | 2023-05-04

US20230136297A1

Human necessities

Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene

#13 | 2022-12-08

US20220387406A1

Human necessities

Methods of treating Fabry patients having renal impairment

#14 | 2022-06-02

US20220168292A1

Human necessities

Methods of treating Fabry patients having renal impairment

#15 | 2022-06-02

US20220168291A1

Human necessities

Methods of treating Fabry patients having renal impairment

#16 | 2022-06-02

US20220168290A1

Human necessities

Methods of treating fabry patients having renal impairment

#17 | 2022-06-02

US20220168289A1

Human necessities

Methods of treating Fabry patients having renal impairment

#18 | 2022-06-02

US20220168288A1

Human necessities

Methods of treating Fabry patients having renal impairment

#19 | 2022-06-02

US20220168287A1

Human necessities

Methods of treating Fabry patients having renal impairment

#20 | 2022-05-26

US20220160691A1

Human necessities

Methods of treating Fabry patients having renal impairment

#21 | 2022-05-12

US20220142998A1

Human necessities

Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene

#22 | 2022-04-07

US20220105079A1

Human necessities

Methods of treating fabry patients having renal impairment

#23 | 2021-12-23

US20210393603A1

Human necessities

Methods of treating Fabry patients having renal impairment

#24 | 2021-12-23

US20210393602A1

Human necessities

Methods of treating Fabry patients having renal impairment

#25 | 2021-12-16

US20210386723A1

Human necessities

Methods of treating Fabry patients having renal impairment

#26 | 2021-12-09

US20210379037A1

Human necessities

Methods of treating Fabry patients having renal impairment

#27 | 2021-12-09

US20210379036A1

Human necessities

Methods of treating Fabry patients having renal impairment

#28 | 2021-12-09

US20210379035A1

Human necessities

Methods of treating Fabry patients having renal impairment

#29 | 2021-12-09

US20210379034A1

Human necessities

Methods of treating Fabry patients having renal impairment

#30 | 2021-11-25

US20210361633A1

Human necessities

Methods of treating Fabry patients having renal impairment

#31 | 2021-10-14

US20210315875A1

Human necessities

Methods of Treating Fabry Disease in Patients Having a Mutation in the GLA Gene

#32 | 2021-08-19

US20210251971A1

Human necessities

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

#33 | 2021-07-22

US20210220344A1

Human necessities

Methods of treating Fabry patients having renal impairment

#34 | 2021-03-25

US20210085661A1

Human necessities

Methods of treating Fabry patients having renal impairment

#35 | 2021-03-25

US20210085660A1

Human necessities

Methods of treating Fabry patients having renal impairment

#36 | 2021-03-11

US20210069162A1

Human necessities

Methods of treating Fabry patients having renal impairment

#37 | 2021-03-11

US20210069161A1

Human necessities

Methods of treating Fabry patients having renal impairment

#38 | 2021-02-11

US20210038625A1

Human necessities

Methods of treating Fabry disease in patients having a mutation in the GLA gene

#39 | 2021-02-11

US20210038583A1

Human necessities

Methods of treating Fabry patients having renal impairment

#40 | 2021-02-11

US20210038582A1

Human necessities

Methods of treating Fabry patients having renal impairment

#41 | 2021-02-11

US20210038581A1

Human necessities

Methods of treating Fabry patients having renal impairment

#42 | 2021-02-04

US20210030730A1

Human necessities

Methods of treating Fabry patients having renal impairment

#43 | 2020-07-16

US20200222378A1

Human necessities

Methods of treating Fabry patients having renal impairment

#44 | 2020-07-09

US20200215043A1

Human necessities

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

#45 | 2020-07-02

US20200206210A1

Human necessities

Methods of treating Fabry patients having renal impairment

#46 | 2020-07-02

US20200206209A1

Human necessities

Methods of treating Fabry patients having renal impairment

#47 | 2020-07-02

US20200206208A1

Human necessities

Methods of treating fabry patients having renal impairment

#48 | 2020-07-02

US20200206207A1

Human necessities

Methods of treating Fabry patients having renal impairment

#49 | 2020-07-02

US20200206206A1

Human necessities

Methods of treating Fabry patients having renal impairment

#50 | 2020-07-02

US20200206205A1

Human necessities

Methods of treating Fabry patients having renal impairment

#51 | 2020-07-02

US20200206204A1

Human necessities

Methods of treating Fabry patients having renal impairment

#52 | 2020-07-02

US20200206203A1

Human necessities

Methods of treating Fabry patients having renal impairment

#53 | 2020-07-02

US20200206202A1

Human necessities

Methods of treating Fabry patients having renal impairment

#54 | 2020-06-18

US20200188375A1

Human necessities

Methods of treating fabry patients having renal impairment

#55 | 2019-06-13

US20190175570A1

Human necessities

Methods of treating Fabry patients having renal impairment

#56 | 2019-01-03

US20190000819A1

Human necessities

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

#57 | 2019-01-03

US20190000818A1

Human necessities

Method to predict response to pharmacological chaperone treatment of diseases

#58 | 2017-09-28

US20170273959A1

Human necessities

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

InventorID:

1992969 ⎘